Ezgi Kasikci

Title: Ezgi Kasikci: Innovator in Chemotherapeutic Agents

Introduction

Ezgi Kasikci is a notable inventor based in Istanbul, Turkey. She has made significant contributions to the field of chemotherapeutics, particularly in the treatment of pancreatic cancer. Her innovative approach combines existing compounds to enhance their efficacy against cancer cells.

Latest Patents

Ezgi Kasikci holds a patent for a chemotherapeutic agent that comprises a combination of alexidine dihydrochloride and sodium pentaborate pentahydrate. This invention details a formulation that includes 2.9 mg of alexidine dihydrochloride and 2.5 mg of sodium pentaborate pentahydrate, which is prepared by adding 0.5 ml of dimethylsulfoxide to the alexidine dihydrochloride compound. The results of her research indicate that this combination reduces pancreatic cancer cell viability by 10% more than using alexidine dihydrochloride alone, suggesting its potential as an effective treatment option.

Career Highlights

Ezgi Kasikci is affiliated with Yeditepe University, where she conducts her research and develops her innovative solutions. Her work has garnered attention for its potential impact on cancer treatment, showcasing her dedication to advancing medical science.

Collaborations

Ezgi collaborates with esteemed colleagues, including Fikrettin Sahin and Esra Aydemir Coban, who contribute to her research efforts and enhance the scope of her projects.

Conclusion

Ezgi Kasikci's innovative work in developing a new chemotherapeutic agent highlights her commitment to improving cancer treatment. Her contributions to the field are significant and demonstrate the potential for combining existing compounds to create more effective therapies.